Christine Knoll
Pediatric Hematology-Oncology · Phoenix, AZNPI 1710009642
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,523 of the $11,106 with a category attached, or 85.7%. 5 manufacturers reported payments, led by Novo Nordisk at 41.9% of the total. Reporting peaked in 2021 at $8,755 and has fallen 99.8% since, to $17 in 2023.
Across 12 payments — averaging $925.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$5K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Global Blood Therapeutics, Inc.$2K
- CSL Behring$1K
- Portola Pharmaceuticals, LLC$125
Across 200 payments — averaging $2086.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novo Nordisk AS$123K
- Agios Pharmaceuticals, Inc.$79K
- Pfizer$58K
- Genentech, Inc.$42K
- Takeda Pharmaceuticals U.S.A., Inc.$38K
- Shire North American Group Inc$33K
- plus $43K from 4 others
What the payments were for
- Consulting fees$9,52386%
- Speaking & faculty fees$1,37012%
- Food & beverage$2132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $4,656 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $3,200 |
| Global Blood Therapeutics, Inc. | 1 | $1,733 |
| CSL Behring | 2 | $1,392 |
| Portola Pharmaceuticals, LLC | 1 | $125 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REBINYN$2,430
- NovoSeven RT$2,160
- OXBRYTA$1,733
- ADVATE$1,600
- ANDEXXA$125
How this compares
$11,106 in reported general payments places this provider in the 80th percentile of 42 pediatric hematology-oncology providers in Arizona.
See all pediatric hematology-oncology providers in Arizona →
Other pediatric hematology-oncology in Phoenix
- Dana SalzbergPhoenix$380K
- Holly MillerPhoenix$132K
- Natasha BalaPhoenix$82K
- Michael MangumPhoenix$75K
- Michael HenryPhoenix$33K
- Alexander NgwubePhoenix$23K
- Thomas GrossPhoenix$21K
- Mario OttoPhoenix$11K
- Shanna WhitePhoenix$7K
- Laura RetsonPhoenix$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.